Login / Signup

Real-world clinical outcomes of the combination of anti-PD-1 antibody, trastuzumab, and chemotherapy for HER2-positive gastric/gastroesophageal junction cancer.

Baorui LiuZhan ShiXin ZhangQin LiuXiaobin CuiLin LiBaorui LiuJia Wei
Published in: Cancer medicine (2023)
This real-world study validated the combination regimen's high efficacy and good tolerance in patients with HER2-positive gastric/GEJ cancer. An increased incidence of brain metastasis was observed in patients who failed this regimen.
Keyphrases
  • papillary thyroid
  • squamous cell
  • risk factors
  • lymph node metastasis
  • squamous cell carcinoma
  • white matter
  • radiation therapy
  • resting state
  • multiple sclerosis
  • functional connectivity